**AI驱动的病理学云平台Proscia完成900万美元C+轮融资**
全球领先的数字病理软件供应商Proscia今日宣布，成功在C+轮融资中筹集了900万美元，使得本轮总融资额达到4600万美元。本轮融资由Highline Capital Management和Triangle Peak Partners共同领投，包括Alpha Intelligence Capital、Scale Venture Partners以及Hitachi Ventures在内的现有投资者也积极参与其中。
这笔资金的注入将为Proscia的商业扩张按下加速键，同时支持其在生命科学和诊断实验室领域中人工智能应用的进一步研发。Proscia的平台以其AI驱动的病理学解决方案著称，此次融资将有助于推动公司在病理诊断的数字化和智能化方面取得新的突破，为医疗行业提供更为精准和高效的诊断工具。
Proscia的首席执行官表示，这笔资金将用于加强公司的市场地位，扩大产品影响力，并持续投资创新，以满足全球病理学界对AI技术日益增长的需求。此次融资不仅彰显了投资者对Proscia技术实力的信任，也标志着公司在推动病理学领域革命性变革的道路上迈出了坚实的步伐。
英语如下：
**AI-Powered Pathology Platform Proscia Raises $9 Million in C+ Round, Accelerating Digital Pathology**
Proscia, a global leader in digital pathology software, has announced the completion of a $9 million C+ funding round, bringing the total raised in this round to $46 million. The round was co-led by Highline Capital Management and Triangle Peak Partners, with participation from existing investors Alpha Intelligence Capital, Scale Venture Partners, and Hitachi Ventures.
The injection of funds will accelerate Proscia’s commercial expansion and support the continued development of its artificial intelligence (AI) applications in the life sciences and diagnostic laboratory sectors. Proscia’s platform is known for its AI-driven pathology solutions, and this financing will propel the company’s advancements in digital and intelligent pathology, providing more accurate and efficient diagnostic tools for the healthcare industry.
The CEO of Proscia stated that the funding will be used to solidify the company’s market position, broaden its product reach, and continue investing in innovation to address the growing demand for AI technology in the global pathology community. This round of financing not only underscores investors’ confidence in Proscia’s technological capabilities but also marks a significant step forward in the company’s mission to drive transformative change in the field of pathology.
【来源】https://venturebeat.com/ai/proscias-46m-series-c-propels-ai-driven-pathology-into-the-mainstream/
Views: 1